Unknown

Dataset Information

0

CRISPR-Cas9-mediated genomic multiloci integration in Pichia pastoris.


ABSTRACT:

Background

Pichia pastoris (syn. Komagataella phaffii) is a widely used generally recognized as safe host for heterologous expression of proteins in both industry and academia. Recently, it has been shown to be a potentially good chassis host for the production of high-value pharmaceuticals and chemicals. Nevertheless, limited availability of selective markers and low efficiency of homologous recombination make this process difficult and time-consuming, particularly in the case of multistep biosynthetic pathways. Therefore, it is crucial to develop an efficient and marker-free multiloci gene knock-in method in P. pastoris.

Results

A non-homologous-end-joining defective strain (?ku70) was first constructed using the CRISPR-Cas9 based gene deficiency approach. It was then used as a parent strain for multiloci gene integration. Ten guide RNA (gRNA) targets were designed within 100 bp upstream of the promoters or downstream of terminator, and then tested using an eGFP reporter and confirmed as suitable single-locus integration sites. Three high-efficiency gRNA targets (PAOX1UP-g2, PTEF1UP-g1, and PFLD1UP-g1) were selected for double- and triple-locus co-integration. The integration efficiency ranged from 57.7 to 70% and 12.5 to 32.1% for double-locus and triple-locus integration, respectively. In addition, biosynthetic pathways of 6-methylsalicylic acid and 3-methylcatechol were successfully assembled using the developed method by one-step integration of functional genes. The desired products were obtained, which further established the effectiveness and applicability of the developed CRISPR-Cas9-mediated gene co-integration method in P. pastoris.

Conclusions

A CRISPR-Cas9-mediated multiloci gene integration method was developed with efficient gRNA targets in P. pastoris. Using this method, multiple gene cassettes can be simultaneously integrated into the genome without employing selective markers. The multiloci integration strategy is beneficial for pathway assembly of complicated pharmaceuticals and chemicals expressed in P. pastoris.

SUBMITTER: Liu Q 

PROVIDER: S-EPMC6704636 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

CRISPR-Cas9-mediated genomic multiloci integration in Pichia pastoris.

Liu Qi Q   Shi Xiaona X   Song Lili L   Liu Haifeng H   Zhou Xiangshan X   Wang Qiyao Q   Zhang Yuanxing Y   Cai Menghao M  

Microbial cell factories 20190821 1


<h4>Background</h4>Pichia pastoris (syn. Komagataella phaffii) is a widely used generally recognized as safe host for heterologous expression of proteins in both industry and academia. Recently, it has been shown to be a potentially good chassis host for the production of high-value pharmaceuticals and chemicals. Nevertheless, limited availability of selective markers and low efficiency of homologous recombination make this process difficult and time-consuming, particularly in the case of multis  ...[more]

Similar Datasets

| S-EPMC5887973 | biostudies-literature
| S-EPMC5518881 | biostudies-literature
| S-EPMC9450370 | biostudies-literature
| S-EPMC5481315 | biostudies-other
| S-EPMC10992869 | biostudies-literature
| S-EPMC7003105 | biostudies-literature
| S-EPMC4586837 | biostudies-other
| S-EPMC6321276 | biostudies-literature
| S-EPMC5331785 | biostudies-literature
| S-EPMC7756923 | biostudies-literature